Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05324228
Other study ID # 300/7
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 3, 2021
Est. completion date September 16, 2022

Study information

Verified date April 2023
Source Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main goal of the study is to determine the physiological parameters of sublingual microcirculation in children in different age categories using Sidestream Dark-Field Imaging Method. No significant differences are expected to be found between measurements in healthy volunteers in different age categories.


Description:

After recording the basic anthropometric parameters, pressure, pulse and O2 saturation, each volunteer who meets the inclusion criteria will have their microcirculation measured using a Sidestream Dark-Field (SDF) probe placed sublingually by one examiner using the SDF method. The measurement will be performed in supine position in a disease-free period, with normal diets, at least 2 hours after the last meal in the afternoon, for girls outside the menses period. Premedication or analgesia will not be used. A total of 3 video clips will be recorded from different parts of the sublingual area with a minimum length of 20 seconds in a row, unless the child needs a short break between measurements. The recorded videos will then be processed offline by one evaluator who is trained and experienced in microcirculation evaluation, three best and most stable parts of each video clip will be analysed.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 16, 2022
Est. primary completion date September 16, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 18 Years
Eligibility Inclusion Criteria: - healthy child - informed consent of parents Exclusion Criteria: - inability to cooperate - acute illness - chronic illness - chronic medication - substance abuse

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Czechia Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. Ústí Nad Labem

Sponsors (1)

Lead Sponsor Collaborator
Vlasta Krausová

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determination of Total Vascular Density of sublingual microcirculation of children Total length of vessels divided by total surface of area baseline
Primary Determination of Microvascular Flow Index (MFI) of sublingual microcirculation of children The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant. The MFI score represents the averaged values of the four. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). baseline
Primary Determination of Small Vessel Density of sublingual microcirculation of children Total length of small vessels divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). baseline
Primary Determination of Proportion of Perfused Vessels (all) of sublingual microcirculation of children The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels. baseline
Primary Determination of Proportion of Perfused Small Vessels (PPV) of sublingual microcirculation of children The proportion of perfused small vessels (PPV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels.
A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
baseline
Primary Determination of Perfused Vessel Density (all) of sublingual microcirculation of children Total length of vessels - (no flow + intermittent flow) divided by total surface of area baseline
Primary Determination of Perfused Small Vessel Density (PVD) of sublingual microcirculation of children Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). baseline
Primary Determination of DeBacker Score of sublingual microcirculation of children In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen. Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines. baseline
Secondary Differences in Total Vascular Density in children of different age categories Total length of vessels divided by total surface of area. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
Secondary Differences in Microvascular Flow Index (MFI) in children of different age categories The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant. The MFI score represents the averaged values of the four. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
Secondary Differences in Small Vessel Density in children of different age categories Total length of small vessels divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
Secondary Differences in Proportion of Perfused Vessels (all) in children of different age categories The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
Secondary Differences in Perfused Vessel Density (all) in children of different age categories Total length of vessels - (no flow + intermittent flow) divided by total surface of area. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
Secondary Differences in Proportion of Perfused Small Vessels (PPV) in children of different age categories The proportion of perfused small vessels (PPV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels.
A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
baseline
Secondary Differences in Perfused Small Vessel Density (PVD) in children of different age categories Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area. A 20 µm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
Secondary Differences in DeBacker Score in children of different age categories In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen. Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines. Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1